InsidersTradesSigma
Explore the complete record of transactions filed by Rovaldi Christopher, 管理人员. Director active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 2 disclosures have been published. Activity tracked since 1 April 2022. The latest transaction was filed on 6 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Christopher Rovaldi is the Chief Operating Officer of Keros Therapeutics, Inc. In this role, he oversees the company's operations and ensures process efficiency. His expertise is essential for the smooth functioning of the organization.